XENETIC BIOSCIENCES, INC. Foreign Currency Transaction Gain, before Tax
XENETIC BIOSCIENCES, INC. (XBIO) reported Foreign Currency Transaction Gain, before Tax of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2016-11-14
- XENETIC BIOSCIENCES, INC. foreign currency transaction gain, before tax for the quarter ending 2016-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. foreign currency transaction gain, before tax for the quarter ending 2015-09-30 was -$1.71K.
| Period end | Foreign Currency Transaction Gain, before Tax 3 month | Foreign Currency Transaction Gain, before Tax 6 month | Foreign Currency Transaction Gain, before Tax 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 | ||
| 2015-09-30 | -$1.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$346.39K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$344.68K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |